Skip navigation
Skip navigation

Tumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales

Clark, Ian A; Atwood, Craig S.; Bowen, Richard; Da Paz Filho, Gilberto; Vissel, Bryce

Description

The evident limitations of the amyloid theory of the pathogenesis of Alzheimer's disease are increasingly putting alternatives in the spotlight. We argue here that a number of independently developing approaches to therapy-including specific and nonspecific anti-tumor necrosis factor (TNF) agents, apolipoprotein E mimetics, leptin, intranasal insulin, the glucagon-like peptide-1 mimetics and glycogen synthase kinase-3 (GSK-3) antagonists-are all part of an interlocking chain of events. All...[Show more]

dc.contributor.authorClark, Ian A
dc.contributor.authorAtwood, Craig S.
dc.contributor.authorBowen, Richard
dc.contributor.authorDa Paz Filho, Gilberto
dc.contributor.authorVissel, Bryce
dc.date.accessioned2015-12-07T22:25:28Z
dc.identifier.issn0031-6997
dc.identifier.urihttp://hdl.handle.net/1885/21298
dc.description.abstractThe evident limitations of the amyloid theory of the pathogenesis of Alzheimer's disease are increasingly putting alternatives in the spotlight. We argue here that a number of independently developing approaches to therapy-including specific and nonspecific anti-tumor necrosis factor (TNF) agents, apolipoprotein E mimetics, leptin, intranasal insulin, the glucagon-like peptide-1 mimetics and glycogen synthase kinase-3 (GSK-3) antagonists-are all part of an interlocking chain of events. All these approaches inform us that inflammation and thence cerebral insulin resistance constitute the pathway on which to focus for a successful clinical outcome in treating this disease. The key link in this chain presently absent is a recognition by Alzheimer's research community of the long-neglected history of TNF induction of insulin resistance. When this is incorporated into the bigger picture, it becomes evident that the interventions we discuss are not competing alternatives but equally valid approaches to correcting different parts of the same pathway to Alzheimer's disease. These treatments can be expected to be at least additive, and conceivably synergistic, in effect. Thus the inflammation, insulin resistance, GSK-3, and mitochondrial dysfunction hypotheses are not opposing ideas but stages of the same fundamental, overarching, pathway of Alzheimer's disease pathogenesis. The insight this provides into progenitor cells, including those involved in adult neurogenesis, is a key part of this approach. This pathway also has therapeutic implications for other circumstances in which brain TNF is pathologically increased, such as stroke, traumatic brain injury, and the infectious disease encephalopathies.
dc.publisherAmerican Society for Pharmacology and Experimental Therapeutics
dc.sourcePharmacological Reviews
dc.subjectKeywords: 2 (2,4 dichlorophenyl) 3 (1 methyl 3 indolyl)maleimide; amyloid beta protein; apolipoprotein E; bexarotene; curcumin; dipeptidyl peptidase IV inhibitor; erythropoietin; glucagon like peptide 1; glycogen synthase kinase 3; glycogen synthase kinase 3 inhibi
dc.titleTumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales
dc.typeJournal article
local.description.notesImported from ARIES
local.identifier.citationvolume64
dc.date.issued2012
local.identifier.absfor111500 - PHARMACOLOGY AND PHARMACEUTICAL SCIENCES
local.identifier.ariespublicationu4492120xPUB16
local.type.statusPublished Version
local.contributor.affiliationClark, Ian A, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationAtwood, Craig S. , University of Wisconsin
local.contributor.affiliationBowen, Richard, OTB Research
local.contributor.affiliationDa Paz Filho, Gilberto, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationVissel, Bryce, Garvan Institute of Medical Research
local.description.embargo2037-12-31
local.bibliographicCitation.issue4
local.bibliographicCitation.startpage1004
local.bibliographicCitation.lastpage1026
local.identifier.doi10.1124/pr.112.005850
dc.date.updated2016-02-24T11:10:42Z
local.identifier.scopusID2-s2.0-84867051523
local.identifier.thomsonID000309551500007
CollectionsANU Research Publications

Download

File Description SizeFormat Image
01_Clark_Tumor_Necrosis_Factor-Induced_2012.pdf780.26 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator